MRI-based tumor inter-fraction motion statistics for rectal cancer boost radiotherapy

References

• Wiltshire KL, Ward IG, Swallow C, et al. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival. Int J Radiat Oncol Biol Phys. 2006;64:709–716.
   PubMed Web of Science ®Google Scholar
• Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010;11:835–844.
   PubMed Web of Science ®Google Scholar
• Habr-Gama A, Perez RO, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy. Ann Surg. 2004;CXXII:309–316.
   Google Scholar
• Appelt AL, Ploen J, Vogelius IR, et al. Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2013;85:74–80.
   PubMed Web of Science ®Google Scholar
• Burbach JPM, den Harder AM, Intven M, et al. Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: a systematic review and meta-analysis. Radiother Oncol. 2014;113:1–9.
   PubMed Web of Science ®Google Scholar
• Janjan NA, Crane CN, Feig BW, et al. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2000;47:713–718.
   PubMed Web of Science ®Google Scholar
• Pfeiffer P. High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: a phase I trial. Acta Oncol (Madr). 2005;44:224–229.
   PubMed Web of Science ®Google Scholar
• Movsas B, Diratzouian H, Hanlon A, et al. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer. Am J Clin Oncol. 2006;29:435–441.
   PubMed Web of Science ®Google Scholar
• Vestermark LW, Jacobsen A, Qvortrup C, et al. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC). Acta Oncol. 2008;47:428–433.
   PubMed Web of Science ®Google Scholar
• Engineer R, Mohandas KM, Shukla PJ, et al. Escalated radiation dose alone vs. concurrent chemoradiation for locally advanced and unresectable rectal cancers: results from phase II randomized study. Int J Colorectal Dis. 2013;28:959–966.
   PubMed Web of Science ®Google Scholar
• Mohiuddin M, Paulus R, Mitchell E, et al. Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancer. Int J Radiat Oncol Biol Phys. 2013;86:523–528.
   PubMed Web of Science ®Google Scholar
• Burbach JPM, Verkooijen HM, Intven M, et al. Randomized controlled trial for pre-operative dose-escalation BOOST in locally advanced rectal cancer (RECTAL BOOST study): study protocol for a randomized controlled trial. Trials. 2015;16:1–8.
   PubMed Web of Science ®Google Scholar
• Burbach JPM, Kleijnen JJE, Reerink O, et al. Inter-observer agreement of MRI-based tumor delineation for preoperative radiotherapy boost in locally advanced rectal cancer. Radiother Oncol. 2016;118:399–407.
   PubMed Web of Science ®Google Scholar
• Kleijnen JJE, Van Asselen B, Burbach JPM, et al. Evolution of motion uncertainty in rectal cancer: implications for adaptive radiotherapy. Phys Med Biol. 2016;61:1–11.
   PubMed Web of Science ®Google Scholar
• Klein S, Staring M, Murphy K, et al. Elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging. 2010;29:196–205.
   PubMed Web of Science ®Google Scholar
• van Herk M, Remeijer P, Rasch C, et al. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47:1121–1135.
   PubMed Web of Science ®Google Scholar
• Brierley JD, Dawson LA, Sampson E, et al. Rectal motion in patients receiving preoperative radiotherapy for carcinoma of the rectum. Int J Radiat Oncol Biol Phys. 2011;80:97–102.
   PubMed Web of Science ®Google Scholar
• Van den Begin R, Kleijnen J-P, Engels B, et al. Tumor volume regression during preoperative chemoradiotherapy for rectal cancer: a prospective observational study with weekly MRI. Acta Oncol. 2018;57(6):723–727. doi:10.1080/0284186X.2017.1400689
   Google Scholar
• Nijkamp J, de Jong R, Sonke J-J, et al. Target volume shape variation during hypo-fractionated preoperative irradiation of rectal cancer patients. Radiother Oncol. 2009;92:202–209.
   PubMed Web of Science ®Google Scholar
• Nijkamp J, de Haas-Kock DFM, Beukema JC, et al. Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands. Radiother Oncol. 2012;102:14–21.
   PubMed Web of Science ®Google Scholar